| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 26.550 | 68.516 | 48.864 | 36.740 | 32.245 | 16.760 | 30 | 26 | 36 | 21 |
| Total Income - EUR | 26.550 | 68.521 | 50.800 | 38.474 | 33.060 | 16.770 | 30 | 26 | 36 | 21 |
| Total Expenses - EUR | 24.848 | 60.261 | 48.953 | 38.057 | 38.026 | 20.288 | 972 | 569 | 62 | 105 |
| Gross Profit/Loss - EUR | 1.702 | 8.260 | 1.847 | 417 | -4.965 | -3.518 | -942 | -543 | -26 | -84 |
| Net Profit/Loss - EUR | 906 | 6.890 | 158 | 32 | -5.296 | -3.536 | -943 | -543 | -26 | -84 |
| Employees | 0 | 1 | 2 | 2 | 2 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Allmedicals Pharma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 2.115 | 7.036 | 5.671 | 4.885 | 4.664 | 4.466 | 4.480 | 2.235 | 2.222 |
| Current Assets | 10.001 | 13.432 | 6.307 | 7.565 | 10.484 | 18.831 | 18.347 | 18.359 | 15.045 | 14.926 |
| Inventories | 8.960 | 17.198 | 15.943 | 16.182 | 16.173 | 16.815 | 16.421 | 16.452 | 14.985 | 14.885 |
| Receivables | 765 | 2.452 | 3.161 | 1.974 | 2.112 | 1.977 | 1.933 | 1.939 | 60 | 38 |
| Cash | 276 | -6.218 | -12.797 | -10.591 | -7.801 | 39 | -7 | -33 | 0 | 3 |
| Shareholders Funds | 951 | 7.004 | 7.046 | 6.949 | 1.518 | -2.046 | -2.944 | -7.045 | -7.050 | -7.094 |
| Social Capital | 45 | 111 | 112 | 110 | 107 | 105 | 103 | 103 | 103 | 103 |
| Debts | 9.050 | 8.543 | 10.128 | 10.048 | 17.539 | 29.159 | 29.294 | 29.884 | 24.330 | 24.242 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Allmedicals Pharma Srl